ConductScience.org, home

Paper24978464

Targeted radiotherapy with gold nanoparticles: current status and future perspectives.

Ngwa W and 7 others. Nanomedicine (Lond), 2014. Cited by 126 papers, by iCite.

Cite this record

ConductScience Library. Targeted radiotherapy with gold nanoparticles: current status and future perspectives. Papers, record 24978464. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24978464

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeted radiotherapy with gold nanoparticles: current status and future perspectives.
PubMed
Journal
Nanomedicine (Lond)
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review
PubMed
Citations, by iCite
126
iCite
Relative citation ratio, by iCite
4.74
iCite
Revised in PubMed
2024-06-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ngwa WWilfred
2Kumar RRajiv
3Sridhar SSrinivas
4Korideck HHouari
5Zygmanski PPiotr
6Cormack RARobert A
7Berbeco RRoss
8Makrigiorgos GMG Mike

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GoldMajor topic
Metal NanoparticlesMajor topic
NeoplasmsMajor topic
Humans
Nanomedicine
Nanotechnology

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K01 CA172478NCI NIH HHSUnited StatesK01CA172478PubMed and NIHNIH RePORTER
R03 CA164645NCI NIH HHSUnited StatesR03CA164645PubMed and NIHNIH RePORTER
R41 EY024197NEI NIH HHSUnited StatesR41EY024197PubMed and NIHNIH RePORTER

Download CSV of grants

References169

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117021318Ranibizumab for neovascular age-related macular degeneration.N Engl J Med2006https://conductscience.org/library/papers/17021318PubMed
219879699Biological in situ dose painting for image-guided radiation therapy using drug-loaded implantable devices.Int J Radiat Oncol Biol Phys2010https://conductscience.org/library/papers/19879699PubMed
319700816Contrast-enhanced radiotherapy: feasibility and characteristics of the physical absorbed dose distribution for deep-seated tumors.Phys Med Biol2009https://conductscience.org/library/papers/19700816PubMed
418712584Intravascular delivery of particulate systems: does geometry really matter?Pharm Res2009https://conductscience.org/library/papers/18712584PubMed
523201628Enhanced proton treatment in mouse tumors through proton irradiated nanoradiator effects on metallic nanoparticles.Phys Med Biol2012https://conductscience.org/library/papers/23201628PubMed
611893639Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy.Br J Radiol2002https://conductscience.org/library/papers/11893639PubMed
723302438Impact of beam quality on megavoltage radiotherapy treatment techniques utilizing gold nanoparticles for dose enhancement.Phys Med Biol2013https://conductscience.org/library/papers/23302438PubMed
817308123Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic death.Cancer Res2007https://conductscience.org/library/papers/17308123PubMed
921858925Nanoscience and nanotechnology: evolving definitions and growing footprint on the scientific landscape.Small2011https://conductscience.org/library/papers/21858925PubMed
1021915155Enhanced relative biological effectiveness of proton radiotherapy in tumor cells with internalized gold nanoparticles.Appl Phys Lett2011https://conductscience.org/library/papers/21915155PubMed
1124588231Biogenic gold nanoparticles: As a potential candidate for brain tumor directed drug delivery.Artif Cells Nanomed Biotechnol2015https://conductscience.org/library/papers/24588231PubMed
1219118040Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy.Clin Cancer Res2009https://conductscience.org/library/papers/19118040PubMed
1311234875Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.Clin Cancer Res2001https://conductscience.org/library/papers/11234875PubMed
142384804Inhomogeneous deposition of radiopharmaceuticals at the cellular level: experimental evidence and dosimetric implications.J Nucl Med1990https://conductscience.org/library/papers/2384804PubMed
152183074516-Gy low-voltage x-ray irradiation followed by as-needed ranibizumab therapy for AMD: 6-month outcomes of a "radiation-first" strategy.Ophthalmic Surg Lasers Imaging2011https://conductscience.org/library/papers/21830745PubMed
1620080552Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20080552PubMed
1720225865Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin.J Am Chem Soc2010https://conductscience.org/library/papers/20225865PubMed
1823423979Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology.Cancer Res2013https://conductscience.org/library/papers/23423979PubMed
1920153731Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice.Biochem Biophys Res Commun2010https://conductscience.org/library/papers/20153731PubMed
2023638079Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization.PLoS One2013https://conductscience.org/library/papers/23638079PubMed

See all 169 referencesDownload CSV of references

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.

PMIDTitleJournalYearIn PapersSource
42570096Range of dose enhancement factor for gold nanoparticles in radiotherapy using Monte Carlo simulations.Radiat Environ Biophys2026https://conductscience.org/library/papers/42570096PubMed
41743230Tumor radiosensitization with gold nanoparticles: evolving strategies to improve tumoral gold uptake and catalyze future clinical translation.ACS Nano Med2026https://conductscience.org/library/papers/41743230PubMed
41189671Advancing cancer radiotherapy: Harnessing radiosensitizers and nanotechnology for enhanced tumor control.Int J Pharm X2025https://conductscience.org/library/papers/41189671PubMed
40050802Engineered multifunctional nanoparticles for enhanced radiation therapy: three-in-one approach for cancer treatment.Mol Cancer2025https://conductscience.org/library/papers/40050802PubMed
40006543Exploring the Potential of Gold Nanoparticles in Proton Therapy: Mechanisms, Advances, and Clinical Horizons.Pharmaceutics2025https://conductscience.org/library/papers/40006543PubMed
39590321Preliminary Study on Lutetium-177 and Gold Nanoparticles: Apoptosis and Radiation Enhancement in Hepatic Cancer Cell Line.Curr Issues Mol Biol2024https://conductscience.org/library/papers/39590321PubMed
38470761An Optimized Method for Evaluating the Potential Gd-Nanoparticle Dose Enhancement Produced by Electronic Brachytherapy.Nanomaterials (Basel)2024https://conductscience.org/library/papers/38470761PubMed
37555189Emulsion Technology in Nuclear Medicine: Targeted Radionuclide Therapies, Radiosensitizers, and Imaging Agents.Int J Nanomedicine2023https://conductscience.org/library/papers/37555189PubMed
36980778The Promise of Nanoparticles-Based Radiotherapy in Cancer Treatment.Cancers (Basel)2023https://conductscience.org/library/papers/36980778PubMed
36979684The Usefulness of Nanotechnology in Improving the Prognosis of Lung Cancer.Biomedicines2023https://conductscience.org/library/papers/36979684PubMed
36743265Gold nanoparticles capped with L-glycine, L-cystine, and L-tyrosine: toxicity profiling and antioxidant potential.J Mater Sci2023https://conductscience.org/library/papers/36743265PubMed
35931743Enhancing nanoparticle accumulation in two dimensional, three dimensional, and xenograft mouse cancer cell models in the presence of docetaxel.Sci Rep2022https://conductscience.org/library/papers/35931743PubMed
35478920A model of modified meta-iodobenzylguanidine conjugated gold nanoparticles for neuroblastoma treatment.RSC Adv2021https://conductscience.org/library/papers/35478920PubMed
35336040Image-Based Quantification of Gold Nanoparticle Uptake and Localization in 3D Tumor Models to Inform Radiosensitization Schedule.Pharmaceutics2022https://conductscience.org/library/papers/35336040PubMed
35057061Incorporation of Low Concentrations of Gold Nanoparticles: Complex Effects on Radiation Response and Fate of Cancer Cells.Pharmaceutics2022https://conductscience.org/library/papers/35057061PubMed
34860272Gold-nanoparticle-enriched breast tissue in breast cancer treatment using the INTRABEAM® system: a Monte Carlo study.Radiat Environ Biophys2022https://conductscience.org/library/papers/34860272PubMed
34771534Application of High-Z Gold Nanoparticles in Targeted Cancer Radiotherapy-Pharmacokinetic Modeling, Monte Carlo Simulation and Radiobiological Effect Modeling.Cancers (Basel)2021https://conductscience.org/library/papers/34771534PubMed
34753117Improving dose calculation accuracy in preclinical radiation experiments using multi-energy element resolved cone-beam CT.Phys Med Biol2021https://conductscience.org/library/papers/34753117PubMed
34104817Current role of nanoparticles in the treatment of lung cancer.J Clin Transl Res2021https://conductscience.org/library/papers/34104817PubMed
33989429EURADOS STRATEGIC RESEARCH AGENDA 2020: VISION FOR THE DOSIMETRY OF IONISING RADIATION.Radiat Prot Dosimetry2021https://conductscience.org/library/papers/33989429PubMed

See all 66 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354NCBI Gene
TF7018PubTator's text mininghttps://conductscience.org/library/genes/7018NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24978464

GET https://conductscience.org/api/papers/v1/24978464/references?page=2